Pancreatic Cancer Research

ResearcherNational Cancer CenterActive in the last 2 years

Young Ae Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3819-0028; OpenAlex author ID A5061053245. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2024: 2 papers · 2025: 2 papers

Papers 4

  1. Increased diagnosis of hepato-biliary-pancreatic cancer after cholecystectomy: a population-based study. Co-author DOI 10.1038/s41598-024-84781-7↗
  2. Effectiveness and cost analysis of liposomal irinotecan in patients with pancreatic adenocarcinoma: a multicenter real-world study. First author DOI 10.1177/17588359251370492↗
  3. Survival benefits of adjuvant chemotherapy after conversion surgery in patients with advanced pancreatic cancer. Co-author DOI 10.3389/fonc.2024.1510016↗
  4. The Trends and Outcomes of Initial Palliative Chemotherapy in Patients with Pancreatic Cancer in Korea Based on National Health Insurance Service Data. First author DOI 10.3390/jcm13113229↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dong Kee Jang · 3 shared papers, 2024–2025 · strength 0.68
  2. Jin‐Hyeok Hwang · 3 shared papers, 2024–2025 · strength 0.68
  3. Yoon Suk Lee · 3 shared papers, 2024–2025 · strength 0.68
  4. Jung Won Chun · 3 shared papers, 2024–2025 · strength 0.68
  5. Sang Myung Woo · 3 shared papers, 2024–2025 · strength 0.68
  6. Jong-Chan Lee · 2 shared papers, 2024–2025 · strength 0.46
  7. Sung‐Sik Han · 1 shared paper, 2025 · strength 0.30
  8. Hyeong Min Park · 1 shared paper, 2025 · strength 0.30
  9. Mee Joo Kang · 1 shared paper, 2025 · strength 0.30
  10. Sang‐Jae Park · 1 shared paper, 2025 · strength 0.30
  11. Woo Jin Lee · 1 shared paper, 2025 · strength 0.25
  12. Jong-chan Lee · 1 shared paper, 2024 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.